Search Within

Eileen O'Reilly

Formats
  1. Meeting Abstract (370)
  2. Journal Article (365)
  3. Review (24)
  4. Book Section (9)
  5. Correspondence (9)
  6. Editorial (8)
  7. Conference Paper (5)
  8. Miscellaneous (5)
  9. Book Whole (4)
  10. Guidelines (3)
  11. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (803)
  2. Department of Medicine (803)
  3. Gastrointestinal Oncology Service (803)
  4. Solid Tumor Oncology Division (803)
  5. Epidemiology and Biostatistics (184)
  6. Surgery (173)

More Groups

People
  1. Ghassan Abou-Alfa (160)
  2. Kenneth Yu (123)
  3. David Kelsen (112)
  4. Maeve Lowery (99)
  5. Marinela Capanu (97)
  6. William Jarnagin (88)

More People

Years
  1. 2025 (50)
  2. 2024 (76)
  3. 2023 (73)
  4. 2022 (57)
  5. 2021 (54)
  6. 2020 (70)

More Years

Publications
  1. Journal of Clinical Oncology (296)
  2. Annals of Oncology (51)
  3. Cancer (28)
  4. Annals of Surgical Oncology (26)
  5. Clinical Cancer Research (23)
  6. Gastrointestinal Cancer Research (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (312)
  2. Oxford University Press (75)
  3. Elsevier Inc. (49)
  4. Springer (47)
  5. Wiley Blackwell (43)
  6. American Association for Cancer Research (40)

More Publishers

Results (803)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of necuparanib combined with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer: Updated phase 1 results
    Meeting Abstract

    O'Reilly, E. M.; Mahalingam, D.; Roach, J. M.; Miller, P. J.; Rosano, M. E.; Krause, S.; Wolf, J.; Flaherty, K.; Ryan, D. P.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase 2, open-label, multicenter study of durvalumab (MEDI4736) ± tremelimumab in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): ALPS
    Meeting Abstract

    O'Reilly, E. M.; Oh, D. Y.; Lee, M. A.; Dhani, N.; Armstrong, J.; Belli, R.; Ferro, S.; Ben, Y.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention
    Meeting Abstract

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Kemeny, N. E.; O'Reilly, E. M.; Jarnagin, W. R.; Harding, J. J.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase 1B trial of ADI-PEG 20 (A) plus nab-paclitaxel (nab-P) and gemcitabine (gem) in subjects with advanced pancreatic cancer (APC)
    Meeting Abstract

    Lowery, M. A.; Capanu, M.; Glassman, D. C.; Covington, C. M.; Gluskin, J.; Brenner, R.; Li, C. F.; Bomalaski, J. S.; Johnston, A.; Barba, A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic profiling of pancreas ductal adenocarcinoma (PDA), actionability, and correlation with clinical phenotype
    Meeting Abstract

    Jordan, E.; Lowery, M. A.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Maynard, H.; Glassman, D. C.; Covington, C. M.; Schultz, N.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Identification of potentially actionable molecular alterations in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Heins, Z. J.; Connell, L. C.; Soumerai, T.; Kemeny, N. E.; Jarnagin, W. R.; O'Reilly, E. M.; DeMatteo, R. P.; D'Angelica, M. I.; Lowery, M. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Second-line chemotherapy (CTx) outcomes in advanced biliary cancers (ABC): A retrospective multicenter analysis
    Meeting Abstract

    Goff, L. W.; Lowery, M. A.; Jordan, E.; Wang, R.; Bocobo, A. G.; Chou, J. F.; O'Reilly, E. M.; Harding, J. J.; Kemeny, N. E.; Capanu, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Is it time to split strategies to treat homologous recombinant deficiency in pancreas cancer?
    Journal Article

    Teo, M. Y.; O'Reilly, E. M.
    Journal of Gastrointestinal Oncology (2016)

    Fulltext@MSK | Save
  • Management of metastatic pancreatic adenocarcinoma
    Journal Article

    Cheema, A. R.; O'Reilly, E. M.
    Surgical Clinics of North America (2016)

    Fulltext@MSK | Save
  • Clinical and molecular analysis of adenosquamous carcinoma of the pancreas
    Journal Article

    Jordan, E. J.; Basturk, O.; Leach, S. D.; Klimstra, D. S.; Allen, P. J.; Berger, M. F.; Askan, G.; Iacobuzio-Donahue, C. A.; Yu, K. H.; O'Reilly, E. M.; more...
    Journal of the Pancreas (2016)

    Fulltext@MSK | Save